Special Offer on Bundled Reports!
If you are having trouble reading this email, read the online version | |
The Analyst’s Take: Top takeaways from SupplySide West 2022
The NBJ team recently attended SupplySide West, which brought together over 16,000 buyers and suppliers from throughout the industry earlier this month. We met with industry leaders and clients, presented data and insights onstage in education, and trend spotted on the show floor. Here are some of our top takeaways: Continued growth in alternative delivery formats: we have been reporting since 2019 that non-pill format sales now eclipse pill format sales for supplements (at 60.8% of total sales in 2021), and we saw continued innovation and science for non-pill formats being promoted by companies across the supply chain. In 2021 another record was reached with gummy supplement sales rising to the top single format at 21.3% of total supplement sales, and companies are both growing and launching to meet this industry demand for the format.Brain health on the brain: brain health popped up as a data theme in three of the education sessions featuring NBJ data and speakers – those on top trends and insights, the microbiome, and nootropics. The market is being driven more than ever by younger consumers looking to optimize and maintain their cognitive function, and trends and innovations show an increased understanding and sophistication around ingredients and function. Examples from the show include growth in plant-based EPA/DHA solutions, and the booming nootropic category, which captured its own education workshop.Expanding microbiome applications: in an NBJ survey of U.S. consumers in June 2022, gut health concerns ranked 6th in the overall list of health issues regularly experienced by consumers – but innovation and science are expanding around optimizing the microbiome to address many other health issues, from mood and mental health to immunity. A full workshop at the event covered all things microbiome, from the science to consumer applications, featuring NBJ market insights. NBJ pinpoints synbiotics as one of the top areas of opportunity, with much stronger growth potential than either prebiotics or probiotics on their own.
|
| |
| | Claire Morton
Claire Morton is the Senior Industry Analyst for New Hope Network's Nutrition Business Journal. She manages NBJ's data and insights to inform the industry on market trends and forecasts in natural and organic food and beverage, functional food and beverage, dietary supplements and personal care. |
|---|
|
| |
| | | Have Your Eye on a Few Reports? Bundle it! |
| | If you've been interested in a few of NBJ's reports but haven't taken the leap yet, now is the perfect opportunity! You can take advantage on this offer now through December 16th, all NBJ reports are included.
Buy three reports for 25% off your total. Enter 25OFF3 at checkout.
Buy four or more reports for 30% off your total. Enter 30OFF4 at checkout.
Offer ends on December 16th, 2022 and cannot be combined with other offers. |
|---|
|
| |
| | We want to hear from you!
We are seeking your insights as we research how the dietary supplements industry is navigating the current economic environment. As an important member of our New Hope and Nutrition Business Journal community, we value your company’s view on the future of this industry. We hope you will take 5-10 minutes to help us get your inside perspective.
As a thank you for your participation in this survey you will receive a free summary of the survey results. You will be able to enter your contact information at the end of the survey to receive this summary in early 2023. Fill out the survey here! |
|---|
|
| |
| | Looking for more industry-leading insights?
Follow us on Linkedin and Twitter for bite-size market stats and exclusive sneak-peeks into our reports and NBJ issues.
|
The NBJ Analyst Take is your bi-weekly analyst, delivered directly to your inbox. Sign up to receive these nuggets of wisdom here. |
| |
|
|
|
This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.
If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email imdatateam@informa.com. 